Published on in Vol 9 (2025)

This is a member publication of

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/68792, first published .
Quality Assessment of Medical Institutions’ Websites Regarding Prescription Drug Misuse of Glucagon-Like Peptide-1 Receptor Agonists by Off-Label Use for Weight Loss: Website Evaluation Study

Quality Assessment of Medical Institutions’ Websites Regarding Prescription Drug Misuse of Glucagon-Like Peptide-1 Receptor Agonists by Off-Label Use for Weight Loss: Website Evaluation Study

Quality Assessment of Medical Institutions’ Websites Regarding Prescription Drug Misuse of Glucagon-Like Peptide-1 Receptor Agonists by Off-Label Use for Weight Loss: Website Evaluation Study

Rie Oyama   1 , MD ;   Tsuyoshi Okuhara   1 , MPH, PhD ;   Emi Furukawa   2 , MD, PhD ;   Hiroko Okada   1 , MPH, PhD ;   Takahiro Kiuchi   1 , MD, PhD

1 Department of Health Communication, School of Public Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

2 University Hospital Medical Information Network, The University of Tokyo Hospital, Tokyo, Japan

Corresponding Author:

  • Rie Oyama, MD
  • Department of Health Communication
  • School of Public Health
  • Graduate School of Medicine, The University of Tokyo
  • 7-3-1 Hongo
  • Bunkyo-ku
  • Tokyo, 113-8655
  • Japan
  • Phone: 81 3-5800-6549
  • Fax: 81 3-5689-0726
  • Email: rooyama-oss@umin.ac.jp